APPROACH

DRI Capital’s strengths as counterparty in royalty monetization transactions include its:

  • Relationship Oriented Approach
  • Breadth of Knowledge
  • Certainty of Deal Execution
  • Access to Capital
LEARN MORE

PORTFOLIO

As a result of these transactions, DRI Capital, through its managed funds, owns royalties on some of the best-selling biopharmaceutical products in the world including:

LEARN MORE

DRI CAPITAL

100 King St. West, Suite 7250
PO Box 62
Toronto, ON M5X 1B1

T: 416-863-1865

APPROACH

DRI Capital’s strengths as counterparty in royalty monetization transactions include its:

  • Relationship Oriented Approach
  • Breadth of Knowledge
  • Certainty of Deal Execution
  • Access to Capital
LEARN MORE

PORTFOLIO

As a result of these transactions, DRI Capital, through its managed funds, owns royalties on some of the best-selling biopharmaceutical products in the world including:

LEARN MORE

DRI CAPITAL

100 King St. West, Suite 7250
PO Box 62
Toronto, ON M5X 1B1

T: 416-863-1865

Investor Relations: